Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ZT-01 for night-time hypoglycemia in Type 1 diabetes; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZT-01

Snippet

Sponsor: Zucara Therapeutics Inc. | Conditions: Type 1 Diabetes Mellitus With Hypoglycemia | Phase 2 | Status: RECRUITING